Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial

Pain

Volumn 109, Issue 1-2, 2004, Pages 26-35

  Sabatowski, Rainer ^a   Gálvez, Rafael ^b   Cherry, David A ^c   Jacquot, Florence ^d   Vincent, Emmanuelle ^d   Maisonobe, Pascal ^d   Versavel, Mark ^d  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d PFIZER INC   (United States)

Author keywords

Chronic pain; Clinical trial; Herpes zoster; Mood; Neuropathic pain; Post herpetic neuralgia; Pregabalin; Sleep

Indexed keywords

GABAPENTIN; PREGABALIN;

ADULT; AGED; ANALGESIC ACTIVITY; ANTICONVULSANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MOOD DISORDER; MULTICENTER STUDY; NEUROPATHIC PAIN; PAIN ASSESSMENT; PATIENT SELECTION; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SLEEP; SOMNOLENCE; TRANQUILIZING ACTIVITY; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HERPES ZOSTER; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; NEURALGIA; PAIN MEASUREMENT; PLACEBOS; QUALITY OF LIFE; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 1842734242     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.01.001     Document Type: Article

References (41)

1. American Geriatrics Society (AGS) Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatrics Soc. 50:2002;S205-S224.
2. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. J Am Med Assoc. 280:1998;1831-1836.
3. Bialer M., Johannessen S.I., Kupferberg H.J., Levy R.H., Loiseau P., Perucca E. Progress report on new antiepileptic drugs: a summary of the Fourth Eilat Conference (EILAT IV). Epilepsy Res. 34:1999;1-41.
4. Bowsher D. Post-herpetic neuralgia in older patients-incidence and optimal treatment. Drugs Aging. 5:1994;411-418.
5. +-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett. 280:2000;107-110.
6. 3H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther. 295:2000;1086-1093.
7. Dworkin R.H., Portenoy R.K. Pain and its persistence in herpes zoster. Pain. 67:1996;241-251.
8. Dworkin R.H., Corbin A.E., Young J.P. Jr, Sharma U., LaMoreaux L., Bockbrader H., Garofalo E.A., Poole R.M. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 60:2003;1274-1283.
9. Engberg I.B., Gröndahl G.B., Thibom K. Patients' experience of herpes zoster and postherpetic neuralgia. J Adv Nurs. 21:1995;427-433.
10. Farrar J.T., Young J.P. Jr, LaMoreaux L., Werth J.L., Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 94:2001;149-158.
11. Feltner D.E., Pollack M.H., Davidson J.R.T., Stein M.B., Futterer R.A., Jefferson J.N., Lydiard R.B. Pregabalin treatment of social phobia. American Psychiatric Association Annual Meeting. 2000;. Abstract NR 256.
12. Filadora V.A., Sist T.C., Lema M.J. Acute herpetic neuralgia and postherpetic neuralgia in the head and neck: response to gabapentin in five cases. Regional Anesthesia Pain Med. 24:1999;170-174.
13. 2+ influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology. 42:2002;229-236.
14. 2δ subunit of a calcium channel. J Biol Chem. 271:1996;5768-5776.
15. Gershon A.A. Epidemiology and management of postherpetic neuralgia. Semin Dermatol. 15:(2, Suppl 1):1996;8-13.
16. Goh C.L., Khoo L. A retrospective study on the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient clinic. Int J Dermatol. 36:1997;667-672.
17. Gureje O., Von Korff M., Simon G.E., Gater R. Persistent pain and well-being: a World Health Organization study in primary care. J Am Med Assoc. 280:(2):1998;147-151.
18. Helgason S., Petursson G., Gudmundsson S., Sigurdsson J.A. Prevalence of postherpetic neuralgia after a single episode of herpes zoster: prospective study with long term follow up. Br Med J. 321:2000;794-796.
19. Hindmarch I, Dawson J, Stanley N. The effects of pregabalin (CI-1008), alprazolam, and placebo on cognitive and psychomotor function, car driving, and aspects of sleep in healthy volunteers. Poster presented at: Annual Meeting of the American College of Neuropsychopharmacology, Waikoloa, HI; December 10, 2001.
20. Jones D.L., Sorkin L.S. Systemic gabapentin and S(+)-3-isobutyl-gamma- aminobutyric acid block secondary hyperalgesia. Brain Res. 81:1998;93-99.
21. Kessler R.C., McGonagle K.A., Zhoa S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 51:1994;8-19.
22. Kost R.G., Straus S.E. Postherpetic neuralgia - pathogenesis, treatment, and prevention. N Engl J Med. 335:1996;32-42.
23. Kubota T., Fang J., Meltzer L.T., Krueger J.M. Pregabalin enhances nonrapid eye movement sleep. J Pharmacol Exp Ther. 299:2001;1095-1105.
24. Lee J.J., Gauci C.A.G. Postherpetic neuralgia: current concepts and management. Br J Hosp Med. 52:1994;565-570.
25. 3H]glutamate from rat caudal trigeminal nucleus slices. Pain. 93:2001;191-196.
26. Max M.B., Schafer S.C., Culnane M., Smoller B., Dubner R., Gracely R.H. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology. 38:1988;1427-1432.
27. Meister W., Neiß A., Gross G., Doerr H.W., Höbel W., Malin J.P., Essen J., von Reimann B.Y., Witke C., Wutzler P. A prognostic score for postherpetic neuralgia in ambulatory patients. Infection. 26:1998;359-363.
28. Melzack R. The short-form McGill Pain Questionnaire. Pain. 30:1987;191-197.
29. Pande A.C., Crockatt J.G., Janey C., Feltner D.E. and the Pregablin GAD Trials Group Pregabalin treatment of GAD. American Psychiatric Association Annual Meeting. 2000;. Abstract NR 244.
30. Rice A.S., Maton S. Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomized, double-blind, placebo-controlled study. Pain. 94:2001;215-224.
31. Rowbotham M.C. Managing post-herpetic neuralgia with opioids and local anesthetics. Ann Neurol. 35:1994;S46-S49.
32. Rowbotham M., Harden N., Stacey B., Bernstein P., Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. J Am Med Assoc. 280:1998;1837-1842.
33. Schmader K. Postherpetic neuralgia in immunocompetent elderly people. Vaccine. 16:1998;1768-1770.
34. Segal A.Z., Rordorf G. Gabapentin as a novel treatment for postherpetic neuralgia. Neurology. 46:1996;1175-1176.
35. Ware J.E. Jr, Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 30:1992;473-483.
36. Watson C.P.N. The treatment of neuropathic pain: antidepressants and opioids. Clin J Pain. 16:2000;49-55.
37. Watson C.P., Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 50:1998;1837-1841.
38. Watson C.P., Evans R.J., Reed K., Merskey H., Goldsmith L., Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 32:1982;671-673.
39. Watson C.P.N., Vernich L., Chipman M., Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia. Neurology. 51:1998;1166-1171.
40. Welty D., Wang Y., Busch J.A., Taylor C.P., Vartanian M.G., Radulovic L.L. Pharmacokinetics and pharmacodynamics of CI-1008 (pregabalin) and gabapentin in rats with maximal electroshock [abstract]. Epilepsia. 388:(Suppl):1997;1110. Abstract 1.110.
41. Zung W.W.K. A self-rating depression scale. Arch Gen Psychiatry. 12:1965;63-70.